Structure–activity relationships and molecular modeling of sphingosine kinase inhibitors

Baek, D. J., MacRitchie, N., Anthony, N. G., Mackay, S. P., Pyne, S., Pyne, N. J. and Bittman, R. (2013) Structure–activity relationships and molecular modeling of sphingosine kinase inhibitors. Journal of Medicinal Chemistry, 56(22), pp. 9310-9327. (doi: 10.1021/jm401399c) (PMID:24164513) (PMCID:PMC3848335)

[img]
Preview
Text
123826.pdf - Published Version
Available under License Creative Commons Attribution.

8MB

Abstract

The design, synthesis, and evaluation of the potency of new isoform-selective inhibitors of sphingosine kinases 1 and 2 (SK1 and SK2), the enzyme that catalyzes the phosphorylation of d-erythro-sphingosine to produce the key signaling lipid, sphingosine 1-phosphate, are described. Recently, we reported that 1-(4-octylphenethyl)piperidin-4-ol (RB-005) is a selective inhibitor of SK1. Here we report the synthesis of 43 new analogues of RB-005, in which the lipophilic tail, polar headgroup, and linker region were modified to extend the structure–activity relationship profile for this lead compound, which we explain using modeling studies with the recently published crystal structure of SK1. We provide a basis for the key residues targeted by our profiled series and provide further evidence for the ability to discriminate between the two isoforms using pharmacological intervention.

Item Type:Articles
Additional Information:The work was supported by NIH Grant HL-083187 (to R.B.) and British Heart Foundation Grant 29476 (to N.J.P. and S.P.).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:MacRitchie, Dr Neil
Authors: Baek, D. J., MacRitchie, N., Anthony, N. G., Mackay, S. P., Pyne, S., Pyne, N. J., and Bittman, R.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Journal of Medicinal Chemistry
Publisher:American Chemical Society
ISSN:0022-2623
ISSN (Online):1520-4804
Published Online:28 October 2013
Copyright Holders:Copyright © 2013 American Chemical Society
First Published:First published in Journal of Medicinal Chemistry 56(22): 9310-9327
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record